Agent for treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient
AssigneeOno Pharmaceutical Co., Ltd.
InventorsYasuto Itoyama, Hiroyuki Kato, Tsutomu Araki
Life of this patent
Estimating the term…
Abstract
An agent for preventing and/or treating Parkinson's disease or Parkinson's syndrome, comprising, as an active ingredient, an astrocyte function-improving agent is disclosed. The astrocyte function-improving agent is preferably a compound represented by formula (I), a non-toxic salt thereof, or a hydrate thereof: R5, R6, R11 and n are defined in the specification.
Claims5
1-7. (canceled)
A method for increasing the content of dopamine in a brain, which comprises administering to a subject in need thereof an effective amount of (R)-2-propylactanoic acid, a non-toxic salt thereof, or a hydrate thereof.
Dependencies are inferred from the claim text.